SL
LMAT icon

Salomon & Ludwin’s LeMaitre Vascular LMAT Stock Holding History

Salomon & Ludwin’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Buy
281
+14
+5% +$1.44K ﹤0.01% 911
2026
Q1 		$29K Buy
267
+208
+353% +$19.8K ﹤0.01% 806
2025
Q4 		$4.83K Sell
59
-11
-16% -$947 ﹤0.01% 1794
2025
Q3 		$6.15K Buy
+70
New +$6.25K ﹤0.01% 1619

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Salomon & Ludwin's LMAT Position: Q2 2026 in Review

Salomon & Ludwin increased its LeMaitre Vascular (LMAT) stake by 5.2% in Q2 2026, buying an estimated $1.44K and bringing the position to 281 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

Salomon & Ludwin first reported a position in LMAT in Q3 2025 and has held it in 4 quarters since. The position peaked at $29K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Salomon & Ludwin held 281 shares of LeMaitre Vascular worth $27.7K as of Q2 2026.
  • Salomon & Ludwin bought 14 LeMaitre Vascular shares in Q2 2026, an estimated $1.44K.
  • LeMaitre Vascular made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #911 holding.
  • Salomon & Ludwin first reported a position in LeMaitre Vascular in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's LeMaitre Vascular position peaked at $29K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.